NPI: 1023397718 · FORT DODGE, IA 50501 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 08/11/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 08/11/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,732 | $179K |
| 2019 | 12,898 | $202K |
| 2020 | 13,563 | $244K |
| 2021 | 12,845 | $225K |
| 2022 | 14,162 | $257K |
| 2023 | 3,768 | $253K |
| 2024 | 1,886 | $176K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 30,380 | 2,008 | $1.45M |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 1,031 | 294 | $33K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 18,040 | 849 | $32K |
| J1756 | Injection, iron sucrose, 1 mg | 4,811 | 807 | $17K |
| 83970 | 920 | 583 | $3K | |
| 83550 | 2,084 | 1,334 | $1K | |
| 83540 | 2,189 | 1,385 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 338 | 230 | $814.29 |
| 82728 | 727 | 476 | $738.47 | |
| 85041 | 1,976 | 1,251 | $468.99 | |
| 85048 | 1,968 | 1,248 | $393.87 | |
| 82108 | 139 | 97 | $300.39 | |
| G0008 | Administration of influenza virus vaccine | 121 | 75 | $86.96 |
| 90674 | 80 | 55 | $66.03 | |
| A4657 | Syringe, with or without needle, each | 2,627 | 1,353 | $38.25 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 423 | 168 | $0.00 |